Maria-Alexandra Papadimitriou Selected Research

Monoclonal Gammopathy of Undetermined Significance

2/2024	Small RNA-seq and clinical evaluation of tRNA-derived fragments in multiple myeloma: Loss of mitochondrial i-tRFHisGTG results in patients' poor treatment outcome.
1/2022	miRNA-seq and clinical evaluation in multiple myeloma: miR-181a overexpression predicts short-term disease progression and poor post-treatment outcome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria-Alexandra Papadimitriou Research Topics

Disease

6	Neoplasms (Cancer) 10/2023 - 01/2019
4	Multiple Myeloma 02/2024 - 12/2021
4	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023 - 01/2019
2	Disease Progression 02/2024 - 01/2022
2	Monoclonal Gammopathy of Undetermined Significance 02/2024 - 01/2022
1	Bone Diseases (Bone Disease) 02/2024
1	Osteolysis 02/2024
1	Carcinoma (Carcinomatosis) 01/2023
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Smoldering Multiple Myeloma 01/2022

Drug/Important Bio-Agent (IBA)

5	MicroRNAs (MicroRNA)IBA 01/2023 - 11/2019
2	RNA (Ribonucleic Acid)IBA 02/2024 - 01/2023
2	Transfer RNA (tRNA)IBA 02/2024 - 12/2020
2	Biomarkers (Surrogate Marker)IBA 12/2021 - 11/2019
1	SYBR Green IIBA 01/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	Small Heat-Shock ProteinsIBA 01/2023
1	Cell-Free Nucleic AcidsIBA 01/2023
1	Long Noncoding RNAIBA 01/2019

Therapy/Procedure

5	Therapeutics 02/2024 - 01/2022
1	Drug Therapy (Chemotherapy) 02/2024